-
ALS Patient's Survival is "One of the Most Powerful Stories" Ever Reported
Monday, August 27, 2012 - 1:43pm | 453Read More...This afternoon, FOX 5 Atlanta will go into the operating room to uncover new details on the landmark surgery of Ted Harada, a 40-year-old man battling ALS. On its Facebook (NASDAQ: FB) page, FOX 5 Atlanta referred to the report as "one of the most powerful stories we've ever reported on the FOX...
-
Landmark Surgery for ALS Patient Ted Harada Set for Today
Wednesday, August 22, 2012 - 7:50am | 315Read More...When Neuralstem (NYSE: CUR) announced that it had been successful in reversing the progression of ALS in 39-year-old Ted Harada, many wondered if researchers were finally on the cusp of a cure. Gizmodo chronicled the impressive story of the man, who showed signs of recovery last year after...
-
Neuralstem Updates ALS Clinical Trial Progress
Monday, October 18, 2010 - 8:12am | 336Read More...Neuralstem, Inc. (NYSE: CUR) updated the progress of its ongoing Phase I human clinical trial of the company's spinal cord stem cells in the treatment of ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) at Emory University in Atlanta, Georgia. The company announced that, after reviewing...
